We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
(-15%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-19.45%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$23.2M |
| 2 |
PepsiCo
PEP
|
+$13.1M |
| 3 |
AbbVie
ABBV
|
+$10.1M |
| 4 |
Elevance Health
ELV
|
+$9.59M |
| 5 |
Abbott
ABT
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22.4M |
| 2 |
Pfizer
PFE
|
+$18M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$13.1M |
| 4 |
Pediatrix Medical
MD
|
+$11.2M |
| 5 |
Danaher
DHR
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.68% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Industrials | 7.26% |
| 4 | Consumer Staples | 5.08% |
| 5 | Communication Services | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRA
76
DELISTED
W.R. Grace & Co.
GRA
| $2.87M | 0.41% |
28,570
+16,392
| +135% | +$1.62M |
|
77
CALL
McDonald's
MCD
$191B
| $2.85M | 0.41% |
+30,000
| New | +$2.9M |
|
|
PF
78
DELISTED
Pinnacle Foods, Inc.
PF
| $2.8M | 0.4% |
61,514
+44,962
| +272% | +$1.9M |
|
|
KRFT
79
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $2.78M | 0.4% |
32,659
-2,462
| -7% | -$212K |
|
80
CALL
Emerson Electric
EMR
$83.3B
| $2.77M | 0.4% |
50,000
-50,000
| -50% | -$2.94M |
|
81
Hilton Worldwide
HLT
$72.5B
| $2.75M | 0.4% |
33,257
+8,584
| +35% | +$754K |
|
|
BEAV
82
CALL
DELISTED
B/E Aerospace Inc
BEAV
| $2.75M | 0.39% |
+50,000
| New | +$2.98M |
|
|
WWAV
83
DELISTED
The WhiteWave Foods Company
WWAV
| $2.74M | 0.39% |
56,097
+6,213
| +12% | +$291K |
|
84
DuPont de Nemours
DD
$18.7B
| $2.73M | 0.39% |
+21,074
| New | +$2.73M |
|
|
ALXN
85
DELISTED
Alexion Pharmaceuticals
ALXN
| $2.71M | 0.39% |
15,000
-7,500
| -33% | -$1.29M |
|
86
CALL
Lennox International
LII
$14.5B
| $2.69M | 0.39% |
+25,000
| New | +$2.78M |
|
87
NXP Semiconductors
NXPI
$61.8B
| $2.66M | 0.38% |
+27,095
| New | +$2.78M |
|
88
Boston Scientific
BSX
$68.4B
| $2.65M | 0.38% |
+150,000
| New | +$2.68M |
|
|
ALR
89
DELISTED
Alere Inc
ALR
| $2.64M | 0.38% |
+50,000
| New | +$2.52M |
|
90
Manitowoc
MTW
$497M
| $2.6M | 0.37% |
+146,226
| New | +$2.67M |
|
91
Apple
AAPL
$4.9T
| $2.58M | 0.37% |
82,336
-68,416
| -45% | -$2.19M |
|
92
Home Depot
HD
$332B
| $2.58M | 0.37% |
+23,235
| New | +$2.6M |
|
93
Stanley Black & Decker
SWK
$14.9B
| $2.55M | 0.37% |
+24,199
| New | +$2.47M |
|
|
GES
94
DELISTED
Guess Inc
GES
| $2.54M | 0.37% |
+132,557
| New | +$2.49M |
|
|
HDP
95
CALL
DELISTED
Hortonworks, Inc.
HDP
| $2.53M | 0.36% |
+100,000
| New | +$2.4M |
|
96
Snap-on
SNA
$21.2B
| $2.51M | 0.36% |
15,788
-27,865
| -64% | -$4.3M |
|
|
OPLN
97
Openlane
OPLN
$4.29B
| $2.5M | 0.36% |
176,322
-286,725
| -62% | -$4.1M |
|
|
CY
98
DELISTED
Cypress Semiconductor
CY
| $2.46M | 0.35% |
208,892
+168,702
| +420% | +$2.22M |
|
99
JetBlue
JBLU
$2.29B
| $2.43M | 0.35% |
117,065
+47,009
| +67% | +$952K |
|
|
AMED
100
DELISTED
Amedisys
AMED
| $2.38M | 0.34% |
+60,000
| New | +$1.87M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.
- Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
- Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
- Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
- Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
- Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
- Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
- Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.
Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.